Oppenheimer Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,486
Closed -$71K 1368
2020
Q1
$71K Sell
6,486
-20,135
-76% -$371K ﹤0.01% 1185
2019
Q4
$568K Sell
26,621
-27,790
-51% -$622K 0.01% 783
2019
Q3
$1.25M Buy
54,411
+4,256
+8% +$90.8K 0.03% 549
2019
Q2
$988K Sell
50,155
-168
-0.3% -$3.27K 0.02% 623
2019
Q1
$980K Buy
50,323
+20,376
+68% +$386K 0.02% 618
2018
Q4
$493K Sell
29,947
-10,232
-25% -$206K 0.01% 770
2018
Q3
$929K Buy
40,179
+18,027
+81% +$408K 0.02% 636
2018
Q2
$481K Buy
22,152
+8,815
+66% +$172K 0.01% 805
2018
Q1
$236K Buy
+13,337
New +$235K 0.01% 1016

Other funds holding SBRA

Oppenheimer Asset Management's SBRA Position: Q2 2020 in Review

Oppenheimer Asset Management sold out of Sabra Healthcare REIT (SBRA) in Q2 2020, closing a stake of 6,486 shares — an estimated $71K sold.

Oppenheimer Asset Management first reported a position in SBRA in Q1 2018 and held it in 9 quarters. The position peaked at $1.25M in Q3 2019. 317 funds tracked by Wall St. Rank hold SBRA as of Q2 2020.

  • Oppenheimer Asset Management reported no remaining Sabra Healthcare REIT position as of Q2 2020 after selling out during the quarter.
  • Oppenheimer Asset Management sold 6,486 Sabra Healthcare REIT shares in Q2 2020, an estimated $71K.
  • Oppenheimer Asset Management first reported a position in Sabra Healthcare REIT in Q1 2018 and held it in 9 quarters.
  • Oppenheimer Asset Management's Sabra Healthcare REIT position peaked at $1.25M in Q3 2019.
  • 317 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2020.

Based on Oppenheimer Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.